- Forums
- ASX - By Stock
- NSB
- Ann: Full Report from Multiple Sclerosis Study
Ann: Full Report from Multiple Sclerosis Study, page-18
Featured News
Add NSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.639M |
Open | High | Low | Value | Volume |
3.9¢ | 3.9¢ | 3.9¢ | $494 | 12.66K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 60000 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 75583 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 60000 | 0.038 |
2 | 313550 | 0.037 |
1 | 100979 | 0.036 |
2 | 214285 | 0.035 |
1 | 100000 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 75583 | 1 |
0.040 | 8000 | 1 |
0.041 | 83335 | 1 |
0.042 | 125000 | 3 |
0.043 | 200000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
NSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online